A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Clinical trial NCT06876662 · RECRUITING
Trial details
- NCT number
- NCT06876662
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2030-05-01
- Enrollment
- 279
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.